Bybit Resumes Full Access for Indian Users, Reinforces Commitment to Compliance and Crypto Inclusion
DUBAI, UAE, Sept. 8, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange…
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz (rilzabrutinib)
LOUISVILLE, Ky., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading…
NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness
TORONTO and HAIFA, Israel, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic…
Olympic Museum announces renewed collaboration with On Location, the Official Hospitality Provider for the Milano Cortina 2026 Olympic and Paralympic Winter Games
08 September 2025 - The Olympic Museum today announced that it has renewed its collaboration…
Sirtex Receives Expanded CE Mark Approval for SIR-Spheres Y-90 Resin Microspheres
Broadened indication increases access to liver cancer treatment across Europe and CE-marked…
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by…
Literacy for All in the Digital Era
Education Cannot Wait funding through its strategic partners provides foundational learning opportunities…
New names set high standards for safety: Togg and firefly shake up the EV market
LEUVEN, BELGIUM – The chances are you won’t have heard of it…
InnoCare Announces Approval of HIBRUKA (Orelabrutinib) for the Treatment of Marginal Zone Lymphoma in Singapore
BEIJING, Sept. 07, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE:…
CATL Launches Shenxing Pro, Europe’s Optimal Solution for E-Mobility at IAA Mobility 2025
MUNICH, Sept. 7, 2025 /PRNewswire/ -- At CATL Open Day, the company…
